Last 12 months
Inside the activity.
0 purchase rows · 49 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 13 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 11 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 11 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 14 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2021 Filed Apr 2, 2021 16:44 UTC |
Legault PierreDirector
|
Exercise / conversionOrdinary Shares | 10,000 | $8.78 | $87,800.00 |
DisclosureSEC source: 0001209191-21-024639 · doc4.xml · nonDerivative · entry 1 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.37827 to GBP 1.00 as of March 31, 2021. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 20:56 UTC |
Gutierrez-Ramos Jose-CarlosDirector
|
GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $27.90 | $0.00 |
DisclosureSEC source: 0001209191-21-022111 · doc4.xml · derivative · entry 1 Gutierrez-Ramos Jose-Carlos · CIK 0001667657 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Ordinary Shares · 32,000 shares Expires 2031-03-17 F1 · derivative.exercise_date: The shares underlying this option shall vest in 36 equal monthly installments at the end of each calendar month following the date of grant. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 16:48 UTC |
Legault PierreDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,784 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001209191-21-022103 · doc4.xml · derivative · entry 3 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,312 Underlying: Ordinary Shares · 7,784 shares Expires 2029-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.3898 to GBP 1.00 as of March 17, 2021. F2 · derivative.exercise_date: This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 16:48 UTC |
Legault PierreDirector
|
SaleOrdinary Shares | 7,784 | $29.00 | $225,736.00 |
DisclosureSEC source: 0001209191-21-022103 · doc4.xml · nonDerivative · entry 2 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 16:48 UTC |
Legault PierreDirector
|
Exercise / conversionOrdinary Shares | 7,784 | $8.85 | $68,888.40 |
DisclosureSEC source: 0001209191-21-022103 · doc4.xml · nonDerivative · entry 1 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.3898 to GBP 1.00 as of March 17, 2021. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 19:41 UTC |
Keen NicholasChief Scientific Officer
|
SaleOrdinary Shares | 217 | $28.00 | $6,076.00 |
DisclosureSEC source: 0001209191-21-021150 · doc4.xml · nonDerivative · entry 3 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,321 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 19:41 UTC |
Keen NicholasChief Scientific Officer
|
SaleOrdinary Shares | 283 | $29.00 | $8,207.00 |
DisclosureSEC source: 0001209191-21-021150 · doc4.xml · nonDerivative · entry 2 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,538 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 19:41 UTC |
Keen NicholasChief Scientific Officer
|
SaleOrdinary Shares | 9,500 | $28.48 | $270,560.00 |
DisclosureSEC source: 0001209191-21-021150 · doc4.xml · nonDerivative · entry 1 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,821 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 19:42 UTC |
Legault PierreDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,216 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001209191-21-021154 · doc4.xml · derivative · entry 3 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,096 Underlying: Ordinary Shares · 2,216 shares Expires 2029-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.39126 to GBP 1.00 as of March 12, 2021. F2 · derivative.exercise_date: This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 19:42 UTC |
Legault PierreDirector
|
SaleOrdinary Shares | 2,216 | $29.00 | $64,264.00 |
DisclosureSEC source: 0001209191-21-021154 · doc4.xml · nonDerivative · entry 2 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 19:42 UTC |
Legault PierreDirector
|
Exercise / conversionOrdinary Shares | 2,216 | $8.86 | $19,633.76 |
DisclosureSEC source: 0001209191-21-021154 · doc4.xml · nonDerivative · entry 1 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.39126 to GBP 1.00 as of March 12, 2021. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 22:28 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 100 | $31.00 | $3,100.00 |
DisclosureSEC source: 0001209191-21-008902 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,800 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 21:34 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 351 | $33.00 | $11,583.00 |
DisclosureSEC source: 0001209191-21-004672 · doc4.xml · nonDerivative · entry 6 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,900 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 21:34 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 100 | $32.02 | $3,202.00 |
DisclosureSEC source: 0001209191-21-004672 · doc4.xml · nonDerivative · entry 5 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,251 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 21:34 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 734 | $31.33 | $22,994.16 |
DisclosureSEC source: 0001209191-21-004672 · doc4.xml · nonDerivative · entry 4 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,351 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 21:34 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 100 | $31.09 | $3,109.00 |
DisclosureSEC source: 0001209191-21-004672 · doc4.xml · nonDerivative · entry 3 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 21:34 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 371 | $30.22 | $11,211.36 |
DisclosureSEC source: 0001209191-21-004672 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,185 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 21:34 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 4,529 | $29.14 | $131,970.08 |
DisclosureSEC source: 0001209191-21-004672 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,556 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 21:29 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001209191-21-004665 · doc4.xml · derivative · entry 3 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,774 Underlying: Ordinary Shares · 15,000 shares Expires 2027-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.36076 to GBP 1.00 as of January 19, 2021. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 21:29 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 15,000 | $30.00 | $450,000.00 |
DisclosureSEC source: 0001209191-21-004665 · doc4.xml · nonDerivative · entry 2 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 21:29 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionOrdinary Shares | 15,000 | $1.59 | $23,850.00 |
DisclosureSEC source: 0001209191-21-004665 · doc4.xml · nonDerivative · entry 1 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F2 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.36076 to GBP 1.00 as of January 19, 2021. Read SEC document |
| January 15, 2021 Filed Jan 15, 2021 21:40 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 5,000 | $27.01 | $135,050.00 |
DisclosureSEC source: 0001209191-21-003822 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 14, 2021 Filed Jan 15, 2021 21:40 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 5,000 | $25.00 | $125,000.00 |
DisclosureSEC source: 0001209191-21-003822 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 14, 2021 Filed Jan 15, 2021 21:44 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001209191-21-003826 · doc4.xml · derivative · entry 3 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,774 Underlying: Ordinary Shares · 10,000 shares Expires 2027-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.36521 to GBP 1.00 as of January 14, 2021. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date. Read SEC document |
| January 14, 2021 Filed Jan 15, 2021 21:44 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 10,000 | $25.00 | $250,000.00 |
DisclosureSEC source: 0001209191-21-003826 · doc4.xml · nonDerivative · entry 2 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 14, 2021 Filed Jan 15, 2021 21:44 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionOrdinary Shares | 10,000 | $1.60 | $16,000.00 |
DisclosureSEC source: 0001209191-21-003826 · doc4.xml · nonDerivative · entry 1 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F2 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.36521 to GBP 1.00 as of January 14, 2021. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 17:26 UTC |
Bourque JaniceDirector
|
GrantStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001327 · doc4.xml · derivative · entry 1 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Ordinary Shares · 19,000 shares Expires 2031-01-04 Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:42 UTC |
Lee KevinDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001400 · doc4.xml · derivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2031-01-04 F1 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares under option on January 4, 2022 and the remaining shares in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 17:36 UTC |
Keen NicholasChief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 70,500 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001372 · doc4.xml · derivative · entry 1 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,500 Underlying: Common Stock · 70,500 shares Expires 2031-01-04 F1 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares under option on January 4, 2022 and the remaining shares in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:33 UTC |
Kalowski LeePresident and CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 70,500 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001359 · doc4.xml · derivative · entry 1 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,500 Underlying: Common Stock · 70,500 shares Expires 2031-01-04 F1 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares under option on January 4, 2022 and the remaining shares in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 17:25 UTC |
BINGHAM KATEDirector
|
GrantStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001321 · doc4.xml · derivative · entry 1 BINGHAM KATE · CIK 0001185040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Ordinary Shares · 19,000 shares Expires 2031-01-04 Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 17:29 UTC |
Jordan Veronica GHDirector
|
GrantStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001341 · doc4.xml · derivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Ordinary Shares · 19,000 shares Expires 2031-01-04 Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 17:39 UTC |
Kender Richard NDirector
|
GrantStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001388 · doc4.xml · derivative · entry 1 Kender Richard N · CIK 0001381205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Ordinary Shares · 19,000 shares Expires 2031-01-04 Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 17:44 UTC |
Legault PierreDirector
|
GrantStock Option (right to buy) · Derivative | 38,000 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001407 · doc4.xml · derivative · entry 1 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Ordinary Shares · 38,000 shares Expires 2031-01-04 Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:50 UTC |
Winter Gregory PaulDirector
|
GrantStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001427 · doc4.xml · derivative · entry 1 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Ordinary Shares · 19,000 shares Expires 2031-01-04 Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:47 UTC |
Smethurst DominicChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 27,621 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001424 · doc4.xml · derivative · entry 1 Smethurst Dominic · CIK 0001820549 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,621 Underlying: Common Stock · 27,621 shares Expires 2031-01-04 F1 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares under option on January 4, 2022 and the remaining shares in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:45 UTC |
Skynner MichaelChief Operating Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 70,500 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001422 · doc4.xml · derivative · entry 1 Skynner Michael · CIK 0001776582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,500 Underlying: Common Stock · 70,500 shares Expires 2031-01-04 F1 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares under option on January 4, 2022 and the remaining shares in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:28 UTC |
Crockett NigelChief Business Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 70,500 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001335 · doc4.xml · derivative · entry 1 Crockett Nigel · CIK 0001788580 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,500 Underlying: Common Stock · 70,500 shares Expires 2031-01-04 F1 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares under option on January 4, 2022 and the remaining shares in 36 equal monthly installments thereafter. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 01:53 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001209191-20-061720 · doc4.xml · derivative · entry 3 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,774 Underlying: Ordinary Shares · 7,500 shares Expires 2027-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.33547 to GBP 1.00 as of December 1, 2020. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 01:53 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 7,500 | $22.50 | $168,750.00 |
DisclosureSEC source: 0001209191-20-061720 · doc4.xml · nonDerivative · entry 2 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 01:53 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionOrdinary Shares | 7,500 | $1.56 | $11,700.00 |
DisclosureSEC source: 0001209191-20-061720 · doc4.xml · nonDerivative · entry 1 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F2 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.33547 to GBP 1.00 as of December 1, 2020. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 21:42 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 530 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001209191-20-060741 · doc4.xml · derivative · entry 3 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,274 Underlying: Ordinary Shares · 530 shares Expires 2027-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.33582 to GBP 1.00 as of November 27, 2020. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 21:42 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 530 | $20.00 | $10,600.00 |
DisclosureSEC source: 0001209191-20-060741 · doc4.xml · nonDerivative · entry 2 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 21:42 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionOrdinary Shares | 530 | $1.56 | $826.80 |
DisclosureSEC source: 0001209191-20-060741 · doc4.xml · nonDerivative · entry 1 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F2 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.33582 to GBP 1.00 as of November 27, 2020. Read SEC document |
| November 25, 2020 Filed Nov 26, 2020 01:31 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,781 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001209191-20-060598 · doc4.xml · derivative · entry 7 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,804 Underlying: Ordinary Shares · 9,781 shares Expires 2027-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.33434 to GBP 1.00 as of November 25, 2020. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F7 · derivative.exercise_date: 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date. Read SEC document |
| November 25, 2020 Filed Nov 26, 2020 01:31 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 9,781 | $20.07 | $196,304.67 |
DisclosureSEC source: 0001209191-20-060598 · doc4.xml · nonDerivative · entry 5 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.24 inclusive. Read SEC document |
| November 25, 2020 Filed Nov 26, 2020 01:31 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionOrdinary Shares | 9,781 | $1.56 | $15,258.36 |
DisclosureSEC source: 0001209191-20-060598 · doc4.xml · nonDerivative · entry 4 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F5 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.33434 to GBP 1.00 as of November 25, 2020. Read SEC document |
| November 23, 2020 Filed Nov 26, 2020 01:31 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,189 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001209191-20-060598 · doc4.xml · derivative · entry 6 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,585 Underlying: Ordinary Shares · 17,189 shares Expires 2027-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.33651 to GBP 1.00 as of November 23, 2020. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F7 · derivative.exercise_date: 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date. Read SEC document |
| November 23, 2020 Filed Nov 26, 2020 01:31 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 213 | $20.38 | $4,340.94 |
DisclosureSEC source: 0001209191-20-060598 · doc4.xml · nonDerivative · entry 3 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.24 to $20.50 inclusive. Read SEC document |
| November 23, 2020 Filed Nov 26, 2020 01:31 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 16,976 | $19.82 | $336,464.32 |
DisclosureSEC source: 0001209191-20-060598 · doc4.xml · nonDerivative · entry 2 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.24 to $20.19 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (6). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.